Rating

Standard and Poor's and AM Best acknowledge the quality of Covéa as a sound counterparty.




Rating in a nutshell






Standard and Poor's Report (2018)



According to S&P Global Ratings, « the combined Covéa group of companies maintains robust operating performance while meeting the challenges of further consolidating its businesses and the unfavorable impact of certain regulations in France. »

The financial rating agency « anticipates that the Covéa group will maintain its strong competitive position. »




AM Best report (2018)



AM Best highlights that « Covéa’s strongest balance sheet assessment is underpinned by the group’s consolidated risk-adjusted capitalisation, which is categorised as strongest per Best’s Capital Adequacy Ratio (BCAR), a conservative and liquid investment portfolio, and a prudent reserving philosophy. »

The rating agency also underlines that « Covéa has a market leading position in the French non-life market, with a large, well-established member base and strong distribution capabilities. »



Attachments

  • 2017 Covéa Financial report

    pdf 1.01 MB Learn more
  • Synthesis of 2017 Covéa financial results

    pdf 1.49 MB Learn more
All documents



These contents may also be of interest to you